| Indicators | Browse All

CDT Equity Inc. (CDT)

Healthcare | Biotechnology | Naples, United States | NasdaqCM
0.44 USD -0.22 (-33.333%) ⇩ (Oct. 13, 2026, 11:45 a.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 6:52 a.m. EDT

The immediate outlook is severely bearish, driven by a catastrophic collapse in share price over the last two weeks. The stock tumbled from $3.55 to $0.72, wiping out nearly 80% of its value in just ten trading days. This freefall occurred despite headlines celebrating a patent win and debt cleanup for its subsidiary, Sarborg, suggesting the market is punishing the equity structure itself—likely due to the announced 1-for-10 reverse stock split which often signals distress or a desperate attempt to meet listing requirements. The technical picture is dire, with the current price sitting far below both the 50-day and 200-day moving averages, confirming a deep downtrend. While the company claims operational progress, the capital markets have overwhelmingly rejected the current valuation, pricing in a failure that outweighs any positive news. There is no safe entry here; the momentum is purely destructive.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.781909
AutoTheta0.837271
AutoETS1.165689
MSTL1.179478

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 28%
H-stat 20.07
Ljung-Box p 0.000
Jarque-Bera p 0.056
Excess Kurtosis -1.04
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.147
Market Cap 17,838
Trailing P/E 0.00
Beta 1.56
Previous Name Conduit Pharmaceuticals Inc.
Website https://www.cdtequity.com

Info Dump

Attribute Value
52 Week Change -0.99997216
Address1 4,581 Tamiami Trail North
Address2 Suite 200
All Time High 1,875,000,060.0
All Time Low 0.631
Ask 1.55
Ask Size 1
Average Daily Volume10 Day 505,890
Average Daily Volume3 Month 201,221
Average Volume 201,221
Average Volume10Days 505,890
Beta 1.556
Bid 0.86
Bid Size 1
Book Value 4,084.023
City Naples
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.44
Current Ratio 0.126
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.6108
Day Low 0.4259
Debt To Equity 1.147
Display Name CDT Equity
Dividend Yield 0.0
Earnings Timestamp End 1,762,977,600
Earnings Timestamp Start 1,762,977,600
Ebitda -22,833,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.02
Enterprise Value 455,768
Eps Trailing Twelve Months 90,812.5
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 32.56174
Fifty Day Average Change -32.121742
Fifty Day Average Change Percent -0.98648727
Fifty Two Week Change Percent -99.997215
Fifty Two Week High 28,125.0
Fifty Two Week High Change -28,124.56
Fifty Two Week High Change Percent -0.9999844
Fifty Two Week Low 0.4146
Fifty Two Week Low Change 0.025399983
Fifty Two Week Low Change Percent 0.061263826
Fifty Two Week Range 0.4146 - 28125.0
Financial Currency USD
First Trade Date Milliseconds 1,648,474,200,000
Float Shares 21,023
Free Cashflow 19,616,876
Full Exchange Name NasdaqCM
Full Time Employees 4
Fullday Change -0.22000003
Fullday Change Percent -33.33334
Fullday Price 0.44
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.33933
Held Percent Institutions 0.00059999997
Implied Shares Outstanding 40,541
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,790,640,000
Last Split Factor 1:25
Long Business Summary CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Long Name CDT Equity Inc.
Market us_market
Market Cap 17,838
Market State REGULAR
Max Age 86,400
Message Board Id finmb_1772079937
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-13
Net Income To Common -37,147,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,847,302
Open 0.5913
Operating Cashflow -11,484,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 646 491 9132
Prev Name Conduit Pharmaceuticals Inc.
Previous Close 0.66
Price Hint 4
Price To Book 0.00010773691
Profit Margins 0.0
Quick Ratio 0.039
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.22000003
Regular Market Change Percent -33.33334
Regular Market Day High 0.6108
Regular Market Day Low 0.4146
Regular Market Day Range 0.4146 - 0.6108
Regular Market Open 0.5913
Regular Market Previous Close 0.66
Regular Market Price 0.44
Regular Market Time 1,791,906,341
Regular Market Volume 683,928
Return On Assets -0.23435
Return On Equity -0.6968
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 40,541
Shares Percent Shares Out 0.9423
Shares Short 38,202
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 1,689
Short Name CDT Equity Inc.
Short Percent Of Float 1.2208
Short Ratio 0.1
Source Interval 15
State FL
Symbol CDT
Total Cash 747,000
Total Cash Per Share 23.739
Total Debt 1,182,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 90,812.5
Trailing P E 0.000004845148
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2,175.4717
Two Hundred Day Average Change -2,175.0317
Two Hundred Day Average Change Percent -0.99979776
Type Disp Equity
Volume 683,928
Website https://www.cdtequity.com
Zip 34,103